Tuesday, 27 September 2022 | 15:00-16:30 | Kursaal
Health data is pivotal to expand disease knowledge, progress R&D and innovation, strengthen and adapt healthcare systems, inform policies and practices; and ultimately improve patients’ lives – all the more so in the area of rare diseases.
How will the European Health Data Space (EHDS), a major pillar of the European Health Union, allow us to build a robust and harmonised European health data ecosystem for rare diseases? How will it help develop a strong evidence base in Europe to support safety, efficacy and value assessment of transformative therapies? What does a successful EHDS look like, that supports quality care for rare disease patients and ensures patient engagement in decisions concerning use of their data?
Join this session to explore the role of the European Health Data Space in defining tomorrow’s care pathways for rare diseases using the case study of haemophilia.